Circulation · 1964 · 23 citations · 11 references
MedicinePharmacologyPharmacotherapyClinical PharmacologyPharmacodynamicsRenal PharmacotherapyCardiovascular PharmacologyHemodynamic PharmacologyHypertension ManagementHypertension PharmacotherapyRenal HemodynamicsRenal PharmacologyAntihypertensive Drug TherapyAntihypertensive PharmacologyAntihypertensive TreatmentCardiac OutputHemodynamic Drug EffectsHypertensive Renal HemodynamicsRenal Hemodynamic EffectsVascular Resistance
Pargyline exerts its antihypertensive effect via a predominant reduction in peripheral vascular resistance, whereas cardiac output is not altered significantly. The effect on renal blood flow is inconsistent, but a significant reduction in glomerular filtration rate does occur. Therefore the drug should be used with appropriate caution in patients with significant impairment of renal function. The hemodynamic response observed with pargyline is similar to that obtained with other MAO inhibitors.
11
The Kidney: Structure and Function in Health and Disease
Postgraduate Medical Journal · 1952 · 1.3K citations
Medicine, Nephrology, Physiology +10
E. A. Stead, James V. Warren, Arthur J. Merrill et al. · Journal of Clinical Investigation · 1945 · 258 citations · Full text
Pharmacodynamic effects of alpha-methyl dopa in hypertensive subjects
G Onesti, Albert N. Brest, Paul Novack et al. · American Heart Journal · 1964 · 79 citations